Avila Science Inc. is developing a pharmaceutical technology solution for early pregnancy loss that combines a two-step medication treatment with 24/7 digital patient support. The New York company aims to turn what can be a two-week or longer process into a fully supported two- to three-day experience for patients and providers.
Incintas Therapeutics, IncFounded by a team that includes business leaders, physicians and reproductive-science specialists, Incintas Therapeutics focuses on a stubborn problem in assisted reproduction: embryos that fail to implant. The company is developing a localized, time-released progesterone therapy for fertility-treatment patients, intended to extend the uterus’s brief period of receptivity.ATGLEN, PA
Medcal PharmacyMedcal Pharmacy is a Brooklyn specialty pharmacy that prepares customized compounded medications and supports patients through fertility, weight-management, and other treatment journeys. Its modern compounding lab is paired with the personal guidance of a neighborhood pharmacy, including one-to-one consultations, help with fertility discount programs, and an in-house delivery team serving patients across several states. Medcal says it has provided fertility support for more than 10 years.BROOKLYN, NY
iCeuticaiCeutica develops improved branded medicines with pharmaceutical partners and from its own pipeline, using its proprietary SoluMatrix™ Fine Particle Technology to make drug particles 10 to 200 times smaller than conventional particles. The scalable process is designed to address bioavailability, dose consistency, side effects and drug delivery, and has supported three FDA-approved products launched in the United States. Based in Princeton with an Australian registered office, iCeutica has applied the technology across pain and inflammation, oncology and respiratory disease programs.KING OF PRUSSIA, PA
Protheragen IncFounded in New York, Protheragen Inc. is a biopharmaceutical incubator that helps turn early-stage drug discoveries into commercial assets. Its integrated approach combines project incubation, early-stage capital support and cross-border business-development consulting, linking scientists and pharmaceutical companies with international partners. The company says it has more than 18 years of industry experience and has managed over 130 projects, with a particular focus on oncology programs.HOLBROOK, NY